Vol 13, No 7 (July 30, 2024): Translational Lung Cancer Research

Original Article

Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors
Yunchang Meng, Yimin Wang, Leilei Liu, Ranpu Wu, Qingfeng Zhang, Zhangxuan Chen, Yang Yao, Xinjing Li, Yanzhuo Gong, Huijuan Li, Zhaofeng Wang, Hongbing Liu
PD-L1 expression from surgically resected lung tumors predictive of early progression in patients previously treated with targeted therapy for initially unresectable non-small cell lung cancer
Jeong Uk Lim, Hye Seon Kang, Mi Hyoung Moon, Chang Dong Yeo, Young Jo Sa, Tae-Jung Kim, Deog Gon Cho, Seok Whan Moon, Kyung Soo Kim
Differential impact of intratumor heterogeneity (ITH) on survival outcomes in early-stage lung squamous and adenocarcinoma based on tumor mutational burden (TMB)
Stanislav Fridland, Hye Sung Kim, Young Kwang Chae
Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data
Gabriela Krakorova, Petr Domecky, Jiri Blazek, Milos Pesek, Ondrej Venclicek, Libor Havel†, Michal Hrnciarik, Jana Krejci, Andrea Mullerova, Miloslav Marel, Jaroslav Duba, Martin Svaton
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers
Mariaenrica Tinè, Federica Pezzuto, Manuela Orlandi, Anna Caliò, Stefano Marletta, Tommaso Bondavalli, Diego Giongo, Daniela Reghellin, Ilaria Posenato, Maria Santacatterina, Andrea Menin, Patrick Karl Welte, Francesca Baciorri, Diana Sacchi, Cosimo Catino, Lorenzo Nicolè, Gabriele Foltran, Alessandra D’Urso, Nicla Orzes, Giulia Andreotti, Patrizia Bartolotta, Dario Gregori, Giulia Pasello, Federico Rea, Fiorella Calabrese
Comparative efficacy and safety of anlotinib and topotecan as second-line treatment in small cell lung cancer: a retrospective cohort study
Yang Du, Xiao-Yan Liu, Xiao-Yan Si, Xiao-Tong Zhang, Jing-Ya Zhou, Yi Wang, Min-Jiang Chen, Li Zhang
Lymph node dissection of station 8 improves the survival of T≤3 cmN0M0 lung adenocarcinoma patients
Tengyong Wang, Zihuai Wang, Hui Jie, Chengwu Liu, Shiyou Wei, Hu Liao, Jiandong Mei, Qiang Pu, Lunxu Liu
Association between thymus density loss and efficacy in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Yi Li, Bingxin Gong, Jie Lou, Yusheng Guo, Bo Liang, Weiwei Liu, Ziang You, Chao Chen, Bin Chai, Shanshan Jiang, Hongyong Zhang, Feng Pan, Lian Yang, Guofeng Zhou
Prognostic relevance of immune-related adverse events in lung cancer patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Yuchen Huang, Wananqi Ma, Dongsheng Wu, Mengyuan Lyu, Quan Zheng, Tengyong Wang, Jian Zhou, Chengwu Liu
Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study
Kazuhito Misawa, Kageaki Watanabe, Masahiro Seike, Yukio Hosomi
Evaluating three-dimensional lung reconstructions for thoracoscopic lung resections using open-source software: a pilot study
Iris E. W. G. Laven, Vincent P. S. Oosterhoff, Aimée J. P. M. Franssen, Lori M. van Roozendaal, Karel W. E. Hulsewé, Yvonne L. J. Vissers, Erik R. de Loos
Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?
Chaoqiang Deng, Chenyu Jiang, Xiangyi Ma, Fangqiu Fu, Shengping Wang, Yuan Li, Yang Zhang, Haiquan Chen
Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases
Ruchira V. Mahashabde, Sajjad A. Bhatti, Bradley C. Martin, Jacob T. Painter, Analiz Rodriguez, Jun Ying, Chenghui Li
Timing of stereotactic radiosurgery within the first-line systemic treatment in non-small cell lung cancer brain metastases: a retrospective single-center cohort study
Raphael Bodensohn, Anna Kolorz, Jonas Reis, Simone Werner, Robert Forbrig, Sylvia Garny, Julian Taugner, Chiara de Colle, Claus Belka, Farkhad Manapov, Louisa von Baumgarten, Maximilian Niyazi
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer
Mau Ern Poh, Sivasubramaniam Balakrishnan, Sin Nee Tan, Muhammad Adil Zainal Abidin, Chong Kin Liam, Jiunn Liang Tan, Yong Kek Pang, Arvindran Alaga, Lye Mun Tho, Soon Hin How
PD-L1 expression in non-small cell lung carcinoma in Latin America: a systematic review and meta-analysis
Rafael Parra-Medina, Juan Pablo Castañeda-González, Luisa Montoya, María Paula Gómez-Gómez, Daniel Clavijo Cabezas, Merideidy Plazas Vargas
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study
Haohua Jiang, Yujing Li, Yanan Wang, Benkun Zou, Ya Chen, Yanwei Zhang, Hatim Husain, Fabien Forest, Fangfei Qian, Lele Zhang, Chao Zhou, Hongyu Liu, Danni Wang, Wei Zhang, Jun Lu, Baohui Han
Sublobar resection for lung adenocarcinoma less than 2 cm containing solid or micropapillary components radiologically presented as consolidation-to-tumor ratio (CTR) ≤0.25 [ground-glass opacity (GGO)]
Mingyang Zhu, Yuanyuan Xu, Jiazheng Huang, Yaxian Yao, Davide Tosi, Terumoto Koike, Nestor R. Villamizar, Ziang Wang, Feng Mao, Qingquan Luo, Qiang Tan
Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations
Xiaoyu Ji, Rongrong Jiang, Tao Liu, Mariano Provencio, Sang Chul Lee, Qiong Zhan, Xinli Zhou
Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib
Qian Cai, Kui Hu, Shuang Dong, Xiaoyu Li, Sheng Hu, Wenyou Deng, Wulin Ou
Age at first sexual intercourse, age at menarche, and age at menopause: a mendelian randomization study on lung cancer risk
Yifan Liu, Xinxin Ying, Yao Li, Xingyu Zhu, Wangwei Jing, Xiaohong Wang, Zhengfu He
miR-16-5p specifically inhibits IFN-γ-regulated memory T helper cell differentiation in malignant pleural effusion of non-small cell lung cancer
Yi Sun, Xiaofen Qiu, Dalei Zhou, Sara Ricciardi, Shuichi Shinohara, Jiangjun Ma